In a presentation at the virtual COA 2020 Conference, Dr Jain discussed the rationale for combining stereotactic RT with immunotherapy in patients with metastatic cancer.
Bo Gamble, Director of Practice Initiatives, COA, discusses how the COVID-19 pandemic is affecting community oncologists nationwide.
Howard “Skip” Burris, III, MD, FACP, FASCO, discusses how community oncologists can overcome common hurdles in the clinical cancer research space.
At the virtual COA 2020 Conference, Dr Grothey discussed the role of gut microbiome in cancer treatment response.
Bo Gamble, Director of Strategic Practice Initiatives, COA, discusses how the Alliance is standing strong in the face of the COVID-19 pandemic.
Stay in the know.
OncNet Newsletter